Products
Amifostine was commercially available as an infusion preparation (Ethyol). It had been approved in many countries since 1996.
Structure and properties
Amifostine (C5H15N2O3PS, Mr = 214.2 g/mol) is a prodrug that is metabolized in tissue to the free thiol.
Effects
Amifostine (ATC V03AF05) is cytoprotective and a free radical scavenger. It protects against chemotherapy-induced acute and cumulative hematologic toxicity and nephrotoxicity.
Indications
- Chemotherapy: reduction of infection risk and nephrotoxicity.
- Radiotherapy: reduction of dry mouth.